A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 72; pp. S69 - S70
Main Authors	Ross, P.J, Repana, D, Saunders, M, Wilson, R.H, Plummer, C.J, Summers, J, Higgins, F, Peacock, J, Harari, D, Bridgewater, J
Format	Journal Article
Language	English
Published	01.02.2017
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(17)30306-4